However melanoma evades the immune system by expressing Programmed Cell Death Ligand 1 (PD-L1), which binds to the Program Cell Death 1 (PD-1) receptor on T-cells and inhibits their cytotoxic T-cell activity. This evidence concerns the gene PDCD1 and melanoma.